{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT03552406: Phase 1 Interventional Unknown status Solid Tumor
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Class:
PROTEIN
Status:
Investigational
Source:
INN:grisnilimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:maridebart cafraglutide [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00460525: Phase 2 Interventional Completed Plasmodium Falciparum Malaria
(2007)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:tusamitamab [INN]
Source URL:
Class:
PROTEIN